The Value and Institutional Impact of an In-System Laboratory Testing During the COVID-19 Pandemic

• Egile Nagusiak: Karen Kaul MD, PhD (Egilea), Kamaljit Singh MD, D (ABMM) (Egilea), Linda Sabatini PhD (Egilea), Chad Konchak MBA (Egilea), Erin McElvania PhD (Egilea), Paige Larkin PhD (Egilea), Rebecca Lindgren BS, MLS (ASCP) (Egilea), Christina Sutherland BS, MT (ASCP) (Egilea), Gustav Granchalek MBA (Egilea), Alfredo Herrada MHA (Egilea), Brian Murray MBA (Egilea), E Matt Charles BS (Egilea), Priya Dugad MS (Egilea), Ekaterina Livschiz BSc (Egilea)
• Formatua: Liburua
• Argitaratua: Elsevier, 2021-04-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

In-system clinical laboratories have proven themselves to be a fundamentally important resource to their institutions during the COVID-19 pandemic of the past year. The ability to provide SARS-CoV-2 molecular testing to our hospital system allowed us to offer the best possible care to our patients,...